Weight-Loss Jabs Slash Risk of 42 Conditions, Including Dementia and Psychotic Disorders
22 Jan 2025
In a major breakthrough for the medical community, a comprehensive study has revealed that weight-loss jabs, specifically GLP-1 receptor agonists (GLP-1RAs), are associated with a significant reduction in the risk of 42 different health conditions. Among the conditions found to be less likely when patients with diabetes took these medications...
Read More
